Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- ICU
- Price
- 2.59
- Stock movement up
- +0.32 (14.10%)
- Company name
- LMF Acquisition Opportunities Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 9.34M
- Ent value
- -360.79K
- Price/Sales
- 10.60
- Price/Book
- 0.81
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -85.20%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ICU does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 10.60 |
| Price to Book | 0.81 |
| EV to Sales | -0.41 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 3.60M |
| EPS (TTM) | -5.18 |
| FCF per share (TTM) | -5.38 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 881.00K |
| Gross profit (TTM) | 840.00K |
| Operating income (TTM) | -13.92M |
| Net income (TTM) | -13.66M |
| EPS (TTM) | -5.18 |
| EPS (1y forward) | -0.44 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 95.35% |
| Operating margin (TTM) | -1580.48% |
| Profit margin (TTM) | -1551.08% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 13.76M |
| Net receivables | 221.00K |
| Total current assets | 14.87M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 15.53M |
| Accounts payable | 2.02M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 4.07M |
| Total liabilities | 4.07M |
| Shareholder's equity | 11.46M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -14.20M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -14.20M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -119.20% |
| Return on Assets | -87.99% |
| Return on Invested Capital | -119.20% |
| Cash Return on Invested Capital | -123.85% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.35 |
| Daily high | 2.60 |
| Daily low | 2.31 |
| Daily Volume | 216K |
| All-time high | 3087.50 |
| 1y analyst estimate | 1.00 |
| Beta | -1.00 |
| EPS (TTM) | -5.18 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ICU | S&P500 | |
| Current price drop from All-time high | -99.92% | -0.89% |
| Highest price drop | -99.99% | -19.00% |
| Date of highest drop | 2 Jan 2026 | 8 Apr 2025 |
| Avg drop from high | -99.57% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
9.34M
Marketcap category
Small-cap
Description
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Employees
19
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page